4595 Stock Overview
Researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Mizuho Medy Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,511.00 |
| 52 Week High | JP¥1,910.00 |
| 52 Week Low | JP¥1,460.00 |
| Beta | 0.88 |
| 1 Month Change | -5.15% |
| 3 Month Change | -6.56% |
| 1 Year Change | -3.76% |
| 3 Year Change | 28.16% |
| 5 Year Change | 7.54% |
| Change since IPO | 573.05% |
Recent News & Updates
Shareholder Returns
| 4595 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 2.3% | -0.1% | 1.9% |
| 1Y | -3.8% | 13.6% | 15.0% |
Return vs Industry: 4595 underperformed the JP Medical Equipment industry which returned 13.6% over the past year.
Return vs Market: 4595 underperformed the JP Market which returned 15% over the past year.
Price Volatility
| 4595 volatility | |
|---|---|
| 4595 Average Weekly Movement | 2.3% |
| Medical Equipment Industry Average Movement | 3.5% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4595 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4595's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 180 | Fuminari Karakawa | www.mizuho-m.co.jp |
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits.
Mizuho Medy Co.,Ltd. Fundamentals Summary
| 4595 fundamental statistics | |
|---|---|
| Market cap | JP¥28.92b |
| Earnings (TTM) | JP¥3.50b |
| Revenue (TTM) | JP¥10.99b |
8.2x
P/E Ratio2.6x
P/S RatioIs 4595 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4595 income statement (TTM) | |
|---|---|
| Revenue | JP¥10.99b |
| Cost of Revenue | JP¥3.09b |
| Gross Profit | JP¥7.90b |
| Other Expenses | JP¥4.40b |
| Earnings | JP¥3.50b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 07, 2025
| Earnings per share (EPS) | 183.58 |
| Gross Margin | 71.90% |
| Net Profit Margin | 31.83% |
| Debt/Equity Ratio | 0% |
How did 4595 perform over the long term?
See historical performance and comparisonDividends
12.6%
Current Dividend Yieldn/a
Payout RatioDoes 4595 pay a reliable dividends?
See 4595 dividend history and benchmarks| Mizuho MedyLtd dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Mar 31 2025 |
| Days until Ex dividend | 0 days |
| Days until Dividend pay date | 94 days |
Does 4595 pay a reliable dividends?
See 4595 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 07:53 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mizuho Medy Co.,Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Masao Yoshida | Tokai Tokyo Intelligence Laboratory Co., Ltd. |